Intrapartum Monitoring Devices Market Size & Forecast Report, 2014 - 2025

The intrapartum monitoring devices market is expected to reach USD 2.83 billion by 2025. The global market is expected to gain a higher CAGR in the forthcoming period. The Intrapartum monitoring devices market is driven by factors such as the rising prevalence of obesity coupled with precarious obstetric care. In addition, rising cases of premature births, enhanced life expectancy, and technological advancements are likely to contribute to market growth in the forthcoming period. The market witnesses several opportunities in form of intrapartum care facilities, ease of access, and affordability. However, low awareness, significant costs, dearth of medical professionals, health issues about maternity care services, rise in the mortality rate of premature babies due to unmet medical needs are likely to create hindrances in the market during the forecast period.

In the cases of delivery, labor pains can prove severe for the baby as well as the mother. For instance, if the mother has heart conditions or any other health anomaly, then monitoring during labor is crucial and needs special attention. Monitoring the mother’s heart rate is crucial and contractions can become much high or low or even go above and below normal values. Apart, intrapartum devices are useful to detect any early signs of anomalies for future diagnosis. For instance, a tocodynamometer is a medical device used to measure the regularity and period of uterine contractions. A fetal heart rate monitor is a medical device used to monitor the heart rate of the fetus. According to WHO, more than 15.0 billion infants face premature births with multiple causes like high blood pressure, infections, and early labor pain.

The market is trifurcated into product, device, and geography. “Device” type dominates the Intrapartum monitoring devices market growth due to rising use of electrodes and frequent purchase. The “Monitors” segment is likely to outgrow in the forthcoming period, standing second to electrodes. Geographical segmentation for the intrapartum monitoring device market spans North America, South America, Europe, Asia-Pacific, the Middle East, and Africa. North America dominates the global market for reasons such as the rising prevalence of diabetes and obesity. Governments’ initiatives about awareness regarding premature birth with highly developed healthcare infrastructure and availability of monitoring test options are likely to fuel the North American market in the forthcoming period.

The European market is likely to gain a strong CAGR in the forthcoming period due to changes in lifestyles and the growing population. European health commission emphasizes enhanced maternal care that helps in reducing maternal mortality rate and infant mortality. Asia-Pacific’s market is expected to gain a higher competitive edge owing to rising demand for improved maternal care and a rise in premature birth difficulties. Large patient pool and government stress on maternal care solutions are fuelling the market growth. In addition, rising initiatives by the governments to increase health awareness and deliver improved maternity conditions are likely to contribute to the growth of the intrapartum monitoring devices market. The Middle Eastern market is likely to gain a positive traction in the forthcoming period due to the rise in fetal care treatment and improved healthcare infrastructure for neonates is likely to add to the intrapartum monitoring devices market growth. Other factors such as rapid growth rate for premature deliveries and population explosion are fuelling the Middle Eastern market.

African intrapartum monitoring devices industry is expected to witness moderate growth in the forecast period on account of developing healthcare infrastructure, less support regarding health awareness by the government pertaining to uncontrolled births, rise in health instability due to less accessibility to treatment and diagnosis. However, activists and NGOs are likely to create favorable healthcare conditions and awareness, which may result in positive progress to regulate the uncontrolled birth rate. The key players in the intrapartum monitoring device industry include Analogic Corporation, Allen Medical Instruments Corporation, Med-Electronics Inc, Paramed Medical Systems, Huntleigh Sonicaid, Natus Medical Inc, and Terason Ultrasound.

Market Segment:

Device Type Outlook (Revenue, USD Million; 2014 - 2025)
    • Monitors
    • Electrodes
        • Fetal Scalp Electrodes
        • Intrauterine Pressure Catheter
        • Transducer for FHR
        • Transducer for Uterine Contractions

Regional Outlook (Revenue, USD Million; 2014 - 2025)
    • North America
        • the U.S.
        • Canada
    • Europe
        • Germany
        • the UK
    • the Asia Pacific
        • China
        • India
    • Latin America
        • Mexico
        • Brazil
    • MEA
        • South Africa